WEKO3
アイテム
Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
http://hdl.handle.net/10295/00006213
http://hdl.handle.net/10295/00006213d37cc2d2-d128-4404-ab1f-f786e74e6046
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2023-02-23 | |||||
タイトル | ||||||
タイトル | Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury | |||||
言語 | en | |||||
言語 | ||||||
言語 | eng | |||||
主題 | ||||||
主題Scheme | Other | |||||
主題 | stroke | |||||
主題 | ||||||
主題Scheme | Other | |||||
主題 | spinal cord injury | |||||
主題 | ||||||
主題Scheme | Other | |||||
主題 | Rho | |||||
主題 | ||||||
主題Scheme | Other | |||||
主題 | Rho kinase | |||||
主題 | ||||||
主題Scheme | Other | |||||
主題 | noncoding RNA | |||||
主題 | ||||||
主題Scheme | Other | |||||
主題 | apoptosis | |||||
主題 | ||||||
主題Scheme | Other | |||||
主題 | inflammation | |||||
主題 | ||||||
主題Scheme | Other | |||||
主題 | axon regrowth | |||||
主題 | ||||||
主題Scheme | Other | |||||
主題 | neurogenesis | |||||
主題 | ||||||
主題Scheme | Other | |||||
主題 | angiogenesis | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | open access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||
作成者 |
Kimura, Tetsu
× Kimura, Tetsu× Horikoshi, Yuta× Kuriyagawa, Chika× Niiyama, Yukitoshi |
|||||
内容記述 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Ischemic strokes (IS) and spinal cord injuries (SCI) are major causes of disability. RhoA is a small GTPase protein that activates a downstream effector, ROCK. The up-regulation of the RhoA/ROCK pathway contributes to neuronal apoptosis, neuroinflammation, blood-brain barrier dysfunction, astrogliosis, and axon growth inhibition in IS and SCI. Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), were previously considered to be non-functional. However, they have attracted much attention because they play an essential role in regulating gene expression in physiological and pathological conditions. There is growing evidence that ROCK inhibitors, such as fasudil and VX-210, can reduce injury in IS and SCI in animal models and clinical trials. Recently, it has been reported that miRNAs are decreased in IS and SCI, while lncRNAs are increased. Inhibiting the Rho/ROCK pathway with miRNAs alleviates apoptosis, neuroinflammation, oxidative stress, and axon growth inhibition in IS and SCI. Further studies are required to explore the significance of ncRNAs in IS and SCI and to establish new strategies for preventing and treating these devastating diseases. | |||||
言語 | en | |||||
出版タイプ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
書誌情報 |
en : INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 巻 22, 号 21, 発行日 2021 |
|||||
収録物識別子 | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1422-0067 | |||||
出版者 | ||||||
出版者 | MDPI | |||||
関連情報 | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.3390/ijms222111573 | |||||
権利情報 | ||||||
権利情報 | © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |